1. Changes in T‐cell subsets identify responders to FcR‐nonbinding anti‐CD3 mAb (teplizumab) in patients with type 1 diabetes. Issue 1 (14th December 2015) Authors: Tooley, James E.; Vudattu, Nalini; Choi, Jinmyung; Cotsapas, Chris; Devine, Lesley; Raddassi, Khadir; Ehlers, Mario R.; McNamara, James G.; Harris, Kristina M.; Kanaparthi, Sai; Phippard, Deborah; Herold, Kevan C. Journal: European journal of immunology Issue: Volume 46:Issue 1(2016) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗